Johnson & Johnson (JNJ) insider trading
Every open-market stock purchase and sale by Johnson & Johnson executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Healthcare.
Insider activity at a glance
- Joaquin Duato (CEO) and 4 others sold $67.8M in the last 90 days.
- Last insider buy: John G Morikis (Director), $258K, 10 months ago.
- Congress: Richard Dean Dr McCormick sold $1K to $15K, 2 months ago.
Last 12 months: insiders bought $258K (1 buy) and sold $155M (16 sales). Last close $265.58 on Sep 11, 2026.
Recent JNJ insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 8, 2026 | Marillyn A Hewson (Director) | Bought (not open market) | $50K |
| Sep 8, 2026 | Eugene A. Woods (Director) | Bought (not open market) | $37.5K |
| Sep 8, 2026 | Daniel E Pinto (Director) | Bought (not open market) | $31.3K |
| Sep 2, 2026 | Timothy Schmid (Chair) | Sold | $6.2M |
| Sep 2, 2026 | Timothy Schmid (Chair) | Sold | $3M |
| Sep 2, 2026 | Timothy Schmid (Chair) | Bought (not open market) | — |
| Sep 2, 2026 | Timothy Schmid (Chair) | Bought (not open market) | — |
| Aug 17, 2026 | Jennifer L Taubert (VP) | Sold | $4M |
| Aug 17, 2026 | Jennifer L Taubert (VP) | Bought (not open market) | — |
| Aug 13, 2026 | Joaquin Duato (CEO) | Sold | $26.7M |
| Aug 13, 2026 | Joaquin Duato (CEO) | Sold | $5.5M |
| Aug 13, 2026 | Joaquin Duato (CEO) | Bought (not open market) | — |
| Aug 6, 2026 | Elizabeth Forminard (C-suite exec) | Sold | $2.4M |
| Aug 6, 2026 | Elizabeth Forminard (C-suite exec) | Sold | $1.7M |
| Aug 6, 2026 | Elizabeth Forminard (C-suite exec) | Bought (not open market) | — |
| Aug 5, 2026 | Joaquin Duato (CEO) | Sold | $10.8M |
| Aug 5, 2026 | Joaquin Duato (CEO) | Sold | $1.7M |
| Jul 30, 2026 | Richard Dean Dr McCormick (Congress) | Sold | $1K–$15K |
| Jul 20, 2026 | Vanessa Broadhurst (VP) | Sold | $5.8M |
| Jul 20, 2026 | Vanessa Broadhurst (VP) | Bought (not open market) | — |
| Jul 20, 2026 | Vanessa Broadhurst (VP) | Bought (not open market) | — |
| Jun 29, 2026 | Thomas H. Kean (Congress) | Sold | $1K–$15K |
| Jun 11, 2026 | Kathryn E Wengel (VP) | Sold | $2.4M |
| Jun 11, 2026 | Kathryn E Wengel (VP) | Bought (not open market) | — |
| Jun 9, 2026 | Marillyn A Hewson (Director) | Bought (not open market) | $50K |
Who's trading JNJ
- Daniel E Pinto, Director: other filings, last Sep 8, 2026
- Eugene A. Woods, Director: other filings, last Sep 8, 2026
- Marillyn A Hewson, Director: other filings, last Sep 8, 2026
- Timothy Schmid, Chair: sold $15.1M (5 sales), last Sep 2, 2026
- Jennifer L Taubert, VP: sold $4M (1 sale), last Aug 17, 2026
- Joaquin Duato, CEO: sold $66.8M (6 sales), last Aug 13, 2026
- Elizabeth Forminard, VP: sold $4.1M (2 sales), last Aug 6, 2026
- Richard Dean Dr McCormick, Congress: bought $8K (1 buy), sold $16K (2 sales), last Jul 30, 2026
- Vanessa Broadhurst, VP: sold $7.3M (2 sales), last Jul 20, 2026
- Thomas H. Kean, Congress: sold $54K (5 sales), last Jun 29, 2026
- Kathryn E Wengel, VP: sold $2.4M (1 sale), last Jun 11, 2026
- Lloyd Doggett, Congress: bought $24K (3 buys), last Jun 9, 2026
- John C Reed, VP: sold $17.3M (4 sales), last May 1, 2026
- Hubert Joly, Director: other filings, last Apr 23, 2026
- Mary C Beckerle, Director: other filings, last Apr 23, 2026
Get free alerts when an insider at Johnson & Johnson files a new trade →